Dr. McVary on future research on BPH treatments
September 27th 2021“I’m looking forward to comparisons of minimally invasive surgery versus medical therapy, that is, at this point, untapped. It's something which we think we have insight into, but we really don't have good data,” says Kevin T. McVary, MD.
Long-term follow-up of OLYMPUS study shows promising results for patients with UTUC
September 27th 2021In a study presented at the 2021 AUA Annual Meeting, Karim Chamie, MD, and coauthors further examine the long-term results of UGN-101 for patients with LG UTUC given the favorable outcomes of the initial OLYMPUS trial.
Aquablation demonstrates success in large prostates
September 25th 2021In a recent study presented at the 2021 AUA Annual Meeting, Naeem Bhojani, MD, FRCSC, David-Dan Nguyen, and co-authors reported the favorable 3-year results of ongoing Aquablation research specifically involving patients with large prostates.
Dr. Asafu-Adjei on the importance of asking patients about their history with ED
September 24th 2021“Figuring out a good, comfortable way to bring that [ED] conversation up…will really pay dividends in other parts of the health care system. It will also allow more people to appropriately get funneled to urology to better address it,” says Denise Asafu-Adjei, MD, MPH.
Dr. McVary discusses individualizing care in men with BPH
September 24th 2021“[BPH treatment] has to be individualized to the motivations of the patient, and also what I call his "phenotype.” How big is his prostate? How bad is this problem? And what is his tolerance for side effects?” says Kevin T. McVary, MD.
Updated male infertility clinical guideline presented at AUA 2021
September 23rd 2021"These data are growing rapidly, and awareness of where we stand right now and the potential that could change as well in the future with new data is important for the practicing urologist,” says Peter N. Schlegel, MD, FACS.
Study results underscore alarming aggressiveness of early stage micropapillary bladder cancer
September 22nd 2021An aggressive treatment, such as bladder removal, may be necessary in patients with early stage micropapillary bladder cancer because the disease may behave more like late-stage conventional urothelial carcinoma.
Dr. Chamie on durability of UGN-101 in low-grade UTUC
September 17th 2021“The reason that [long-term follow up is] important is because if you look at the best of hands, the incidence of recurrence of upper tract urothelial carcinoma, even for low and intermediate risk, is still very high,” says Karim Chamie, MD.
Dr. Elliott on new developments for treating anterior urethral strictures
September 16th 2021"The take-home message is that Optilume is safe, and that it's superior to standard DVIU or dilation for the treatment of recurrent anterior urethral strictures that are less than 3 cm in length," says Sean P. Elliott, MD, MS, FACS.